Mexico - Delayed Quote MXN

Johnson & Johnson (JNJ.MX)

2,999.10
+26.11
+(0.88%)
As of 11:18:43 AM CST. Market Open.

Research Analysis

Revenue vs. Earnings

Revenue 21.89B
Earnings 6.71B

Q2'24

Q3'24

Q4'24

Q1'25

0
5B
10B
15B
20B
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 15152221
Avg. Estimate 22.85B23.1B91.3B95.03B
Low Estimate 22.51B22.91B90.09B93.09B
High Estimate 23.09B23.24B91.87B96.65B
Year Ago Sales 22.45B22.47B88.82B91.3B
Sales Growth (year/est) 1.78%2.80%2.79%4.09%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
JNJ.MX --------
S&P 500 13.13%2.45%7.54%14.08%

Upgrades & Downgrades

Reiterates RBC Capital: Outperform to Outperform 6/5/2025
Downgrade Leerink Partners: Outperform to Market Perform 5/13/2025
Maintains Barclays: Equal-Weight to Equal-Weight 4/17/2025
Maintains Raymond James: Outperform to Outperform 4/16/2025
Maintains Morgan Stanley: Equal-Weight to Equal-Weight 4/16/2025
Reiterates RBC Capital: Outperform to Outperform 4/16/2025

Related Tickers

ABBV.MX AbbVie Inc.
3,600.00
0.00%
 
BIIB Biogen Inc.
135.52
+1.02%
 
ABBV AbbVie Inc.
190.41
+0.29%
 
LLY Eli Lilly and Company
802.89
+4.28%